Canaccord Genuity reiterated a Buy rating on Edwards Lifesciences (NYSE: EW), and raised the price target to $180.00 (from $178.00) ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments Analyst EPS Change Analyst EPS View Analyst PT Change

Pre-Open Stock Movers 10/27: (TRIV) (UQM) (BABA) Higher; (RRTS) (RCII) (MRVL) Lower (more...)October 27, 2015 9:31 AM UBS Raises Price Target on Edwards Lifesciences (EW) Following Strong 3Q Results October 27, 2015 8:57 AM After-Hours Movers 10/26: (TRIV) (IDTI) (EW) Higher; (RCII) (MRVL) (MSTR) Lower (more...)October 26, 2015 5:51 PM Edwards Lifesciences (EW) Tops Q3 EPS by 9c, Q4 & FY Guidance Tops ViewsOctober 26, 2015 4:18 PM Edwards Lifesciences Reports Third Quarter ResultsOctober 26, 2015 4:15 PM Martha Marsh Appointed To Edwards Lifesciences Board Of DirectorsOctober 23, 2015 9:15 AM